Holen Sie sich die Stockscreener-App
0.5352
68.35%
0.2173
Handel nachbörslich:
.53
-0.0052
-0.97%
Finanzdaten der Estrella Immunopharma Inc-Aktie (ESLA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Expenses
|
9.07%
2.0842
|
2.2921 | 0.6132 | 4.8011 | 5.544 |
| Operating Income/Loss |
9.07%
-2.0842
|
-2.2921 | -0.6132 | -4.8011 | -5.544 |
| Nonoperating Income/Loss |
-0.2221
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
0.62%
-2.3063
|
-2.2921 | -0.6132 | -4.8011 | -5.544 |
| Net Income/Loss |
0.62%
-2.3063
|
-2.2921 | -0.6132 | -4.8011 | -5.5449 |
| Basic Average Shares |
2.08%
43.00
|
42.12 | - | 37.10 | 36.17 |
| Diluted Average Shares |
2.08%
43.00
|
42.12 | - | 37.10 | 36.17 |
| Basic Earnings Per Share |
0.00%
-0.05
|
-0.05 | - | -0.13 | -0.15 |
| Diluted Earnings Per Share |
0.00%
-0.05
|
-0.05 | - | -0.13 | -0.15 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):